Quick Take Vol. 84
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
After completing this activity, the learner will be able to: Apply guideline-based benzodiazepine tapering strategies, including appropriate pace, patient selection, and coordination between inpatient and outpatient settings. Evaluate the evidence for semaglutide as add-on therapy for managing metabolic risk in patients with schizophrenia treated with olanzapine or clozapine. Evaluate EPA-predominant omega-3 supplementation as adjunctive therapy for treatment-resistant depression and its proposed mechanisms of action. Identify current evidence and methodological limitations of ketogenic diets for the management of depression and other psychiatric conditions. Describe how psychotherapy-assisted antidepressant tapering compares to maintenance treatment in terms of relapse risk in patients with remitted depression.
Fields of Study & Subjects
Treatment of Major Depression
Schizophrenia research and treatment
Mental Health Treatment and Access
Publication details
- Publication date
- 27 February 2026
- Language
- EN